CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 32,700 shares at an average $30.47 ($996,238)
- 4/A Open-market buy Director bought 73,170 shares at $41.00 ($2,999,970)
- 8-K Event Results of operations
- 10-K Report Annual Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,331 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Clinical Operations gave up 1,956 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 1,117 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,561 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 6,805 shares (to pay taxes)
- 4 Open-market buy Director bought 29,000 shares at $35.94 ($1,042,393)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
Page 5 of 15 · 282 filings